Correction to: Neurochem Res DOI 10.1007/s11064-017-2386-6

The original version of Figure 4A contained superfluous text. This has now been removed. The correct Fig. 4 is given below:

Fig. 4
figure 4

Adapted from [23]

Elevating cellular ATP with RibAde inhibits LTP via adenosine A1Rs. a LTP induced by a tetanus (100 Hz/1 s; arrow) resulted in robust LTP in standard aCSF, but steadily decremented to baseline in slices pre-incubated in RibAde. b This decrementing LTP was prevented by the adenosine A1R antagonist 8-CPT (1 µM). Inset are fEPSPs taken before (solid lines) and at 60 min after the induction of LTP (dashed lines) in standard aCSF (control) and RibAde-treated slices. c–e Decreasing the number of TBS pulses (80, 40, 20, respectively) induced LTP, which is consistently lower in RibAde-treated slices. 20 TBS pulses (0.5× TBS; e) failed to induce significant LTP above baseline. f Summary of LTP at 60 min induced in a (tetanus; open symbols), c–e. Data for 120 pulses from the LTP (at 30 min) induced by 3× TBS used to evoke the adenosine release in Fig. 5A. Grey arrowheads indicate where LTP was not significantly greater than baseline in RibAde-treated slices. A two-way ANOVA (standard aCSF or RibAde treatment vs number of pulses) showed a significant effect of treatment on the LTP evoked by the various stimulation protocols (F1,51 = 6.47688; p = 0.014).